Unite the Union

Unite the Union

January 31, 2008 11:18 ET

Unite Reaction to AstraZeneca's Proposed Job Cuts

LONDON, UNITED KINGDOM--(Marketwire - Jan. 31, 2008) -

Attention: News, Industrial, Pharmaceutical & North West

Unite the union has grave concerns that AstraZeneca's proposed job cuts of 244 skilled scientific roles from its Alderley Park, Cheshire site will have not only a drastic effect on the local area but also that of the wider UK.

Unite says that the loss of these highly skilled jobs will have a significant effect on the UK pharmaceutical industry, which is currently a world leader, and its ability to develop and discover new drugs.

Pharmaceutical companies add significant value to the UK economy. The industry spends Pounds Sterling 3.2billon on research and development in the UK, accounting for almost 10% of global R&D spending.

Unite National Officer, Linda McCulloch, said:

"Pharmaceutical research is vital to the industry itself and to the overall prosperity of the UK. We believe that the loss of these highly skilled roles will have long term detrimental effects on the economy and the UK skills base.

"Unite also has concerns that people will be deterred from studying science subjects in school and university which again will have damaging consequences of the UK's ability to compete in the global economy.

"We will be strongly representing the views of our members and trying to mitigate these proposed redundancies. We will be meeting with the company immediately to minimise any compulsory redundancies."

AstraZeneca also has sites in Avonmouth, Brixham, Edinburgh, Leicestershire, Macclesfield and London.

Contact Information

  • Linda McCulloch
    07958 514706
    or
    Unite Press Office
    Ashraf Choudhury
    020 7420 8914 or 07980 224761